To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
VC-backed Dyne Therapeutics goes public
Dyne Therapeutics Inc, a muscle disease company, has raised about $233 million for its IPO after pricing its over 12.2 million shares at $19 per share.
